Stockscreener 앱 받기
0.9187
2.07%
0.0186
시장 영업 전:
.92
0.0013
+0.14%
Cocrystal Pharma Inc 주식(COCP)의 최신 뉴스
Cocrystal Pharma Inc (COCP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cocrystal Pharma Inc (COCP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
COCP|Cocrystal Pharma Inc|Price:0.919|Chg%:+0.019 - TradingKey
Cocrystal Pharma Inc Revenue Breakdown – FWB:8CC - TradingView
Cocrystal Pharma Inc (COCP) Institutional Confidence - TradingKey
Cocrystal Pharma Inc (COCP) Cash Flow - TradingKey
Cocrystal Pharma Inc (COCP) Income Statement - TradingKey
COCP|Cocrystal Pharma Inc|Price:0.900|Chg%:-0.020 - TradingKey
Cocrystal Pharma Inc Revenue Breakdown – LS:A3DWYX - TradingView
What's Driving the Micro-Cap Mania in SKYQ and COCP - Kavout | AI
Cocrystal Pharma Inc. (COCP) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Cocrystal Pharma Inc (COCP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cocrystal Pharma Inc (COCP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cocrystal Pharma, Inc. SEC Filing July 2026: Common Stock on Nasdaq, Company Details & Executive Information - Minichart
Cocrystal Pharma Shareholders Approve Governance and Oversight Measures - TipRanks
Cocrystal Pharma (NASDAQ: COCP) investors reelect full board and ratify 2026 auditor - Stock Titan
Price to book forward of Cocrystal Pharma Inc – FWB:8CC - TradingView
Cocrystal Pharma (COCP) Holds Near Key Support After Slight DeclinePCR Extreme - dars.gov.et
COCPCocrystal Pharma Inc Dividends - Finviz
Cocrystal Pharma Holds Steady at $1.05 as Traders Eye Key Support and Resistance LevelsBreakout Trade - dars.gov.et
Cocrystal Pharma (COCP) Inches Up as Stock Tests Key Resistance LevelsSynthetic Long - dars.gov.et
Enterprise value to revenue forward of Cocrystal Pharma, Inc. – NASDAQ:COCP - TradingView
Price to earnings forward of Cocrystal Pharma, Inc. – NASDAQ:COCP - TradingView
Price to sales forward of Cocrystal Pharma, Inc. – NASDAQ:COCP - TradingView
Price to book forward of Cocrystal Pharma Inc – LS:A3DWYX - TradingView
Cocrystal Pharma Inc Actuals & Estimates (NASDAQ:COCP) - TradingView
Cocrystal Pharma(COCP) Stock Options Chain | Quotes & News - Moomoo
COCP Forecast — Price Target — Prediction for 2027 - TradingView
8CC Forecast — Price Target — Prediction for 2027 - TradingView
Cocrystal Pharma Inc (COCP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cocrystal Pharma Inc. Q1 2026 Earnings: Wider-Than-Expected Loss Despite Positive Stock MovementDiluted EPS Report - dars.gov.et
Cocrystal Pharma Company Profile & Introduction - Moomoo
Cocrystal Pharma Inc (COCP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cocrystal Pharma Inc (COCP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cocrystal Pharma Inc (COCP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cocrystal Pharma Appoints New CEO to Lead Transition - The Globe and Mail
Cocrystal Pharma Appoints James Sapirstein as New CEO – Leadership Transition and Company Details - Minichart
Cocrystal Pharma appoints James Sapirstein as CEO with new compensation package By Investing.com - Investing.com South Africa
Cocrystal Pharma appoints James Sapirstein as CEO with new compensation package - Investing.com India
James Sapirstein becomes CEO of Cocrystal Pharma (NASDAQ: COCP) - Stock Titan
COCP Q1 2026 Earnings: EPS Misses as Pre-Revenue Biotech Continues Development SpendingRetail Earnings Report - dars.gov.et
Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer - Moomoo
Cocrystal Pharma taps longtime biotech exec as its new CEO - The Business Journals
Cocrystal Pharma Inc. (COCP) Q1 2026 Earnings: Wider-than-expected Loss as R&D Pipeline ProgressesEarnings Whisper Number - newsline.com
Cocrystal Pharma (COCP) CEO awarded 235,000 stock options under 2025 plan - Stock Titan
Cocrystal Pharma (COCP) CEO James Sapirstein files initial Form 3 - Stock Titan
Cocrystal Pharma names James Sapirstein as CEO - The Pharma Letter
Cocrystal Pharma Inc. Announces CEO Changes - marketscreener.com
Cocrystal Pharma Names New CEO to Drive Antiviral Pipeline - TipRanks
Cocrystal Pharma names James Sapirstein as new CEO By Investing.com - Investing.com South Africa
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer - BioSpace
Cocrystal Pharma names James Sapirstein as new CEO - Investing.com
Veteran antiviral leader James Sapirstein to head Cocrystal Pharma (NASDAQ: COCP) - Stock Titan
Cocrystal Pharma Appoints James Sapirstein, Biopharma - GlobeNewswire
COCP: Presentation Highlights CDI-988 - Zacks Small Cap Research
1.97%
0.83%
자본화:
|
볼륨(24시간):